These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38194018)

  • 21. Radiomic Detection of EGFR Mutations in NSCLC.
    Rossi G; Barabino E; Fedeli A; Ficarra G; Coco S; Russo A; Adamo V; Buemi F; Zullo L; Dono M; De Luca G; Longo L; Dal Bello MG; Tagliamento M; Alama A; Cittadini G; Pronzato P; Genova C
    Cancer Res; 2021 Feb; 81(3):724-731. PubMed ID: 33148663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
    Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
    Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
    Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
    Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying epidermal growth factor receptor mutation status in patients with lung adenocarcinoma by three-dimensional convolutional neural networks.
    Xiong JF; Jia TY; Li XY; Yu W; Xu ZY; Cai XW; Fu L; Zhang J; Qin BJ; Fu XL; Zhao J
    Br J Radiol; 2018 Dec; 91(1092):20180334. PubMed ID: 30059241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.
    Liu Y; Kim J; Balagurunathan Y; Li Q; Garcia AL; Stringfield O; Ye Z; Gillies RJ
    Clin Lung Cancer; 2016 Sep; 17(5):441-448.e6. PubMed ID: 27017476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand.
    Aye PS; Tin Tin S; McKeage MJ; Khwaounjoo P; Cavadino A; Elwood JM
    BMC Cancer; 2020 Jul; 20(1):658. PubMed ID: 32664868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients.
    Kim S; Lim JH; Kim CH; Roh J; You S; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Heo J
    Sci Rep; 2024 Jan; 14(1):922. PubMed ID: 38195717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer.
    Yamazaki M; Yagi T; Tominaga M; Minato K; Ishikawa H
    Br J Radiol; 2022 Dec; 95(1140):20220374. PubMed ID: 36115683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between EGFR mutation and computed tomography characteristics of the lung in patients with lung adenocarcinoma.
    Qiu X; Yuan H; Sima B
    Thorac Cancer; 2019 Feb; 10(2):170-174. PubMed ID: 30516345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
    Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
    [No Abstract]   [Full Text] [Related]  

  • 31. [The value of CT radiomics in the prediction of EGFR mutation in lung cancer].
    Yu YX; Wang XM; Shi C; Hu S; Hu CH
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(9):690-695. PubMed ID: 32187913
    [No Abstract]   [Full Text] [Related]  

  • 32. High accuracy epidermal growth factor receptor mutation prediction via histopathological deep learning.
    Zhao D; Zhao Y; He S; Liu Z; Li K; Zhang L; Zhang X; Wang S; Che N; Jin M
    BMC Pulm Med; 2023 Jul; 23(1):244. PubMed ID: 37407963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study.
    Wang S; Yu H; Gan Y; Wu Z; Li E; Li X; Cao J; Zhu Y; Wang L; Deng H; Xie M; Wang Y; Ma X; Liu D; Chen B; Tian P; Qiu Z; Xian J; Ren J; Wang K; Wei W; Xie F; Li Z; Wang Q; Xue X; Liu Z; Shi J; Li W; Tian J
    Lancet Digit Health; 2022 May; 4(5):e309-e319. PubMed ID: 35341713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma.
    Hsu JS; Huang MS; Chen CY; Liu GC; Liu TC; Chong IW; Chou SH; Yang CJ
    J Thorac Imaging; 2014 Nov; 29(6):357-63. PubMed ID: 25303964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations.
    Li M; Zhang L; Tang W; Duan JC; Jin YJ; Qi LL; Wu N
    Cancer Imaging; 2019 Nov; 19(1):77. PubMed ID: 31783917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on
    Koyasu S; Nishio M; Isoda H; Nakamoto Y; Togashi K
    Ann Nucl Med; 2020 Jan; 34(1):49-57. PubMed ID: 31659591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between EGFR mutation status of lung cancer and preoperative factors - are they predictive?
    Usuda K; Sagawa M; Motono N; Ueno M; Tanaka M; Machida Y; Matoba M; Taniguchi M; Tonami H; Ueda Y; Sakuma T
    Asian Pac J Cancer Prev; 2014; 15(2):657-62. PubMed ID: 24568474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
    Lee EY; Khong PL; Lee VH; Qian W; Yu X; Wong MP
    Clin Nucl Med; 2015 Mar; 40(3):e190-5. PubMed ID: 25608155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.
    Chang C; Zhou S; Yu H; Zhao W; Ge Y; Duan S; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Yan H; Sun X; Xie W
    Eur Radiol; 2021 Aug; 31(8):6259-6268. PubMed ID: 33544167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.